Lymph node ratio predicts recurrence in papillary thyroid cancer

Oncologist

Volumn 18, Issue 2, 2013, Pages 157-162

  Schneider, David F ^a   Mazeh, Haggi ^a   Chen, Herbert ^a   Sippel, Rebecca S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Lymph node metastases; Lymph node ratio; Quality measure; Recurrence; Thyroid cancer

Indexed keywords

ADULT; AGED; CANCER RECURRENCE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; THYROID CANCER; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84874357839     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0240     Document Type: Review

References (38)

1. Grubbs EG, Evans DB. Role of lymph node dissection in primary surgery for thyroid cancer. J Natl Compr Canc Netw 2007;5:623-630.
2. Noguchi S, Noguchi A, Murakami N. Papillary carcinoma of the thyroid: Developing pattern of metastasis. Cancer 1970; 26:1053-1060.
3. Qubain SW, Nakano S, Baba M et al. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 2002;131: 249-256.
4. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: A 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-518.
5. Wada N, Suganuma N, Nakayama H et al. Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes. Arch Surg 2007;392: 417-422.
6. Zaydfudim V, Feurer ID, Griffin MR, Phay JE. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008;144:1070-1078.
7. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer 2006;106:524-531.
8. Scheumann GF, Gimm O, Wegener G et al. Prognostic significance and surgical management of locoregional lymph node mestastases in papillary thyroid cancer. World J Surg 1994;18:559-567.
9. Schuff KG, Weber SM, Givi B et al. Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 2008; 118:768-775.
10. Sippel RS, Chen H. Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid 2009;19:1373-1380.
11. Sacks W, Fung CH, Chang JT et al. The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: A systematic analysis of the peer-reviewed literature from 1966 to April 2008. Thyroid 2010;20:1235-1245.
12. Iyer NG, Morris LG, Tuttle RM et al. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer 2011;117:4439-4446.
13. Ahn JE, Lee JH, Yi JS et al. Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer. World J Surg 2008;32:1552-1558.
14. Kloos RT. Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. J Clin Endocrinol Metab 2010;95:5241-5248.
15. Sywak M, Cornford L, Roach P et al. Routine ipsilateral level VI lymphadenectomy reduces post-operative thyroglobulin levels in papillary thyroid cancer. Surgery 2006;140:1000-1005.
16. Hughes DT, White ML, Miller BB et al. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 2010; 148:1100-1106.
17. Tisell LE, Nilsson B, Molne J et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg 1996;20: 854-859.
18. Mazzaferri EL, Doherty GM, Steward DL. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 2009;19:683-689.
19. Engstrom PF, Benson AB, Chen YJ et al. Colon cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005;3:468-491.
20. Chagpar AB, Scoggins CR, Martin RC et al. Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J 2007;13: 233-237.
21. Leboulleux S, Rubino C, Baudin E et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005;90:5723-5729.
22. Bardet S, Malville E, Rame JP et al. Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol 2008;158:551-560.
23. Sugitani I, Kasai N, Fujimoto Y et al. A novel classification system for patients with PTC: Addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004;135:139-148.
24. Ricarte-Filho J, Ganly I, Rivera M et al. Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. Thyroid 2012;22:575-584.
25. Mocellin S, Pasquali S, Rossi CR et al. Validationof the prognostic value of lymph node ratio in patients with cutaneous melanoma: A population-based study of 8,177 cases. Surgery 2011;150:83-90.
26. Beal SH, Chen SL, Schneider PD et al. An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg 2010;76:28-32.
27. Hughes CJ, Shaha AR, Shah JP et al. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched-pair analysis. Head Neck 1996;18:127-132.
28. Podnos YD, Smith D, Wagman LD et al. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 2005;71:731-734.
29. Byar DP, Green SB, Dor P et al. A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979;15:1033-1041.
30. Hay ID, Grant CS, Taylor WF et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1095.
31. Cady B, Rossi R. An expanded view of riskgroup definition in differentiated thyroid carcinoma. Surgery 1988;104:947-953.
32. Hay ID, Bergstralh EJ, Goellner JR et al. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114:1050-1057.
33. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
34. Sherman SI, Brierley JD, Sperling M et al. Prospective multicenter study of thyroid carcinoma treatment: Initial analysis of staging and out-come. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 1998;83: 1012-1021.
35. Ito Y, Fukushima M, Tomoda C et al. Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J 2009;56:759-766.
36. Poehls JL, Chen H, Sippel RS. Preoperative ultrasonography findings predict the need for repeated surgery in papillary thyroid cancer. Endocr Pract 2012;18:403-409.
37. Porterfield JR, Factor DA, Grant CS. Operative technique for modified radical neck dissection in papillary thyroid carcinoma. Arch Surg 2009;144: 567-574.
38. Ito Y, Tomoda C, Uruno T, Takamura Y et al. Preoperative ultrasonographic examination for lymph node metastasis: Usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg 2004;28: 498-501.